What is the Cumberland Pharmaceuticals Inc. stock price forecast?

Cumberland Pharmaceuticals Inc. is currently trading at $5.67. View real-time AI analysis on Alpha Lenz.

What is Cumberland Pharmaceuticals Inc. insider trading activity?

View the latest insider trading data for Cumberland Pharmaceuticals Inc. on Alpha Lenz.

What is Cumberland Pharmaceuticals Inc.'s P/E ratio?

Cumberland Pharmaceuticals Inc.'s P/E ratio is -29.7.

Cumberland Pharmaceuticals Inc.

NASDAQ · CPIX

$5.67+0.07(+1.25%)Pre-market

Ask about Cumberland Pharmaceuticals Inc.'s future dividend policy...

Alpha Chat Insight

“Cumberland Pharmaceuticals Inc. trades at a P/E of -29.7 (undervalued) with modest ROE of -11.9%.”

Ask for details →

Company Overview

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company that focuses on the development and commercialization of innovative prescription products aimed at improving patient care. The company primarily operates in the healthcare sector, offering a portfolio of niche-market prescription products that address significant medical needs. Cumberland's product range includes treatments for hospital acute care settings, gastroenterology, and oncology, catering to specific therapeutic segments. Founded in 1999 and headquartered in Nashville, Tennessee, the company leverages a network of direct salesforce alongside partnerships with other health care providers and distributors to ensure broad product availability across the United States market. Cumberland Pharmaceuticals plays a critical role in the healthcare industry by providing essential medications that enhance treatment outcomes and address unmet medical needs. Its commitment to expanding therapeutic options and improving patient access to specialized treatments underscores its significance in the pharmaceutical market.

CEOMr. A. J. Kazimi MBA

Websitehttps://www.cumberlandpharma.com

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees91

Company Statistics

FY 2025

Profile

$84.23MMarket Cap

$44.52MRevenue

0.00Shares Out

91Employees

Margins

85.02%Gross

6.67%EBITDA

-6.27%Operating

-6.31%Pre-Tax

-6.43%Net

Valuation

-29.70P/E

3.39P/B

1.89EV/Sales

27.81EV/EBITDA

17.73P/FCF

Growth (CAGR)

1.95%Rev 3Yr

3.52%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-3.76%ROA

-11.88%ROE

-3.04%ROIC

Financial Health

$11.44MCash & Cash Equivalents

$40.84MNet Debt

213.00%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Cumberland Pharmaceuticals Inc. trades at a P/E of -29.7 (undervalued) with modest ROE of -11.9%.”

Ask for details →

Frequently Asked Questions

Cumberland Pharmaceuticals Inc. (ticker: CPIX) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 91 employees. Market cap is $84M.

The current price is $5.67 with a P/E ratio of -29.7x and P/B of 3.39x.

ROE is -11.88% and operating margin is -6.27%. Annual revenue is $45M.